Pre-clinical studies showed that exogenous expression of human IL-24 in a broad spectrum of human cancer cell lines resulted in potent anti-tumor and anti-metastatic activity both in vitro and in vivo [23–25]. The gene discussed is IL24; the disease is cancer.